home / stock / cara / cara short
Short Information | Cara Therapeutics Inc. (NASDAQ:CARA)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 6,482,826 |
Total Actual Volume | 31,857,385 |
Short Trends | |
---|---|
Cover Days | 19 |
Short Days | 0 |
No Change Days | 1 |
Averages | |
---|---|
Average Short Volume | 324,141 |
Average Short Percentage | 24.87% |
Is there a CARA Short Squeeze or Breakout about to happen?
See the CARA Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-19-2024 | $0.35 | $0.3445 | $0.3549 | $0.338 | 337,384 | 104,912 | 31.1% |
07-18-2024 | $0.3409 | $0.347 | $0.357 | $0.3236 | 925,187 | 292,769 | 31.64% |
07-17-2024 | $0.36 | $0.341 | $0.3898 | $0.34 | 1,019,056 | 284,210 | 27.89% |
07-16-2024 | $0.3457 | $0.37 | $0.3754 | $0.3358 | 977,810 | 229,530 | 23.47% |
07-15-2024 | $0.35 | $0.335 | $0.358 | $0.3316 | 1,170,599 | 245,208 | 20.95% |
07-12-2024 | $0.36 | $0.3528 | $0.3798 | $0.3333 | 1,094,773 | 325,649 | 29.75% |
07-11-2024 | $0.31 | $0.366 | $0.41 | $0.3097 | 7,844,171 | 1,742,106 | 22.21% |
07-10-2024 | $0.2847 | $0.286 | $0.295 | $0.279 | 505,525 | 140,007 | 27.7% |
07-09-2024 | $0.2849 | $0.2854 | $0.299 | $0.272 | 632,492 | 202,833 | 32.07% |
07-08-2024 | $0.29 | $0.285 | $0.3079 | $0.281 | 931,470 | 135,070 | 14.5% |
07-05-2024 | $0.278 | $0.2848 | $0.2899 | $0.2721 | 393,534 | 78,160 | 19.86% |
07-03-2024 | $0.271 | $0.272 | $0.289999 | $0.268 | 258,856 | 92,739 | 35.83% |
07-02-2024 | $0.2735 | $0.2779 | $0.2909 | $0.2651 | 677,906 | 232,038 | 34.23% |
07-01-2024 | $0.272 | $0.263 | $0.284 | $0.261 | 971,251 | 206,556 | 21.27% |
06-28-2024 | $0.285 | $0.258 | $0.31 | $0.258 | 6,217,701 | 151,898 | 2.44% |
06-27-2024 | $0.3001 | $0.3045 | $0.3198 | $0.2716 | 796,269 | 150,872 | 18.95% |
06-26-2024 | $0.34 | $0.29 | $0.3689 | $0.29 | 868,467 | 183,823 | 21.17% |
06-25-2024 | $0.33 | $0.3312 | $0.34 | $0.3151 | 847,455 | 247,060 | 29.15% |
06-24-2024 | $0.2787 | $0.3399 | $0.349 | $0.2775 | 2,401,096 | 617,250 | 25.71% |
06-21-2024 | $0.262 | $0.277 | $0.3288 | $0.2574 | 2,986,383 | 820,136 | 27.46% |
News, Short Squeeze, Breakout and More Instantly...
Cara Therapeutics Inc. Company Name:
CARA Stock Symbol:
NASDAQ Market:
Cara Therapeutics Inc. Website:
– Study achieved primary endpoint of Worst Itch-Numeric Rating Scale score change from baseline at Week 8 (p=0.001) – – Onset of action seen at Week 1 and sustained through Week 8 – – Statistical significance achieve...
KORSUVA™ (difelikefalin) injection U.S. commercial launch began in April 2022 and is tracking to expectation Kapruvia ® (difelikefalin) approved by European Commission for the treatment of moderate-to-severe pruritus associated with chronic kidney disease...
STAMFORD, Conn., May 03, 2022 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), an early commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus, today announced that Christopher Posner, President an...